Research Topics
| Maria Patricia RiveraSummaryAffiliation: University of North Carolina Country: USA Publications
| Collaborators
|
Detail Information
Publications
Lung cancer in women: the differences in epidemiology, biology and treatment outcomesMaria Patricia Rivera
University of North Carolina at Chapel Hill, 4133 Bioinformatics Building CB 7020, Chapel Hill, NC 27516, USA
Expert Rev Respir Med 3:627-34. 2009....
Preinvasive lesions of the bronchusM Patricia Rivera
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of North Carolina at Chapel Hill, 4133 Bioinformatics Building, Mason Farm Road, CB 7020, Chapel Hill, NC 27516, USA
Clin Chest Med 32:693-702. 2011..Molecular alterations have been described in preinvasive lesions and may help better predict which lesions will progress. Several noninvasive techniques are available for the treatment of high-grade lesions...- Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancerM Patricia Rivera
Multidisciplinary Thoracic Oncology Group, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7248, USA
Chest 135:1588-95. 2009.... - Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)M Patricia Rivera
University of North Carolina at Chapel Hill, 4133 Bioinformatics Building, CB No 7020, Chapel Hill, NC 27599, USA
Chest 132:131S-148S. 2007.... - Management of patients with advanced non-small-cell lung cancerM P Rivera
Department of Pulmonary and Critical Care Medicine, University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599 7020, USA
Curr Opin Pulm Med 7:247-58. 2001..The performance status of patients with advanced non-small-cell lung cancer is the most important determinant of response to chemotherapy... - Gender and lung cancerM Patricia Rivera
Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, 4133 Bioinformatics Building CB 7020, Chapel Hill, NC 27599, USA
Clin Chest Med 25:391-400. 2004..When guidelines for screening, preventive therapies, and treatment options for lung cancer are outlined these differences should be considered... - Diagnosis of lung cancer: the guidelinesM Patricia Rivera
Department of Medicine, The University of North Carolina at Chapel Hill, 420 Burnett Womack Boulevard, CB No 7020, Chapel Hill, NC 27599, USA
Chest 123:129S-136S. 2003..Recommendations are graded in terms of strength to provide clinicians with guidance as to the most efficient and approach to the diagnosis of lung cancer in individual patients... - The prevalence of clinically relevant incidental findings on chest computed tomographic angiograms ordered to diagnose pulmonary embolismWilliam B Hall
Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, Campus Box 7020, 130 Mason Farm Rd, Chapel Hill, NC 27514
Arch Intern Med 169:1961-5. 2009..Our objective was to determine the prevalence and management implications of incidental findings on chest CTAs ordered to assess for PE... - Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancerCarrie B Lee
Division of Hematology Oncology, Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center at University of North Carolina at Chapel Hill, North Carolina, USA
J Thorac Oncol 4:74-9. 2009..Dose escalation of radiotherapy is one strategy used to improve locoregional control and survival, but it increases the risk of both early and late treatment related toxicities... - Long-term follow-up of a phase I/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA/B non-small cell lung cancerThomas E Stinchcombe
Division of Hematology Oncology, Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7305, USA
J Thorac Oncol 3:1279-85. 2008.... - Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small ceThomas E Stinchcombe
Multidisciplinary Thoracic Oncology Program, 3009 Old Clinic Building CB 7305, Chapel Hill, NC 27599 7305, USA
J Thorac Oncol 3:250-7. 2008..We investigate the tolerability of gefitinib in combined modality therapy in combination with three-dimensional thoracic conformal radiation therapy (3-dimensional TCRT)... - Seeking a home for a PET, part 2: Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancerFrank C Detterbeck
Division of Cardiothoracic Surgery, Department of Surgery, Members of the Multidisciplinary Thoracic Oncology Program, University of North Carolina, Chapel Hill, NC, USA
Chest 125:2300-8. 2004..It is unclear and controversial whether a biopsy is needed in patients with clinical stage II lung cancer who have no PET uptake in the mediastinum... - Beliefs among physicians in the diagnostic and therapeutic approach to non-small cell lung cancerThomas E Stinchcombe
Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA
J Thorac Oncol 2:819-26. 2007..Physicians' beliefs and practice patterns may differ significantly from established guidelines. We conducted a survey to assess and compare physician beliefs against the evidence-based guidelines... - Seeking a home for a PET, part 1: Defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or massesFrank C Detterbeck
Division of Cardiothoracic Surgery, Department of Surgery, University of North Carolina at Chapel Hill, USA
Chest 125:2294-9. 2004.... - Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trialMark A Socinski
Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, CB 7305, Chapel Hill, NC 27599 7305, USA
J Clin Oncol 22:4341-50. 2004..Dose escalation using three-dimensional thoracic conformal radiation therapy (TCRT) is one strategy to improve local control and perhaps survival... - Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphomaSuzanne E Biehn
University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599 7295, USA
Hematol Oncol 24:234-7. 2006..Physicians utilizing rituximab should be aware of this association given the difficulty of differentiating between presentations of BOOP and neoplastic pulmonary processes... - Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonistsGerard A Silvestri
Medical University of South Carolina, Room 812 CSB, 171 Ashley Ave, Charleston, SC 29425, USA
Chest 128:3975-84. 2005..It is important for pulmonologists to be aware of this class of compounds, as they can provide benefit to patients with NSCLC who may not have been previously considered for antitumor therapy... - Guidelines on treatment of stage IIIB non-small cell lung cancerJames R Jett
Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Chest 123:221S-225S. 2003..Treatment of stage IIIB due to malignant pleural effusion is addressed in the section that deals with stage IV disease... - Detection of pre-invasive lung cancer: technical aspects of the LIFE projectGordon P Flake
Laboratory of Experimental Pathology, National Institute of Environmental Sciences, NIH, Research Triangle Park, NC 27709, USA
Toxicol Pathol 35:65-74. 2007.... - Smoking is associated with increased telomerase activity in short-term cultures of human bronchial epithelial cellsHyeon Woo Yim
Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA
Cancer Lett 246:24-33. 2007..An increase in telomerase activity in normal bronchial epithelium might extend the lifespan of cells at risk for malignant transformation, and thus contribute to lung carcinogenesis... - Chromosomal abnormalities in bronchial epithelium from smokers, nonsmokers, and lung cancer patientsRobbert J C Slebos
Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA
Cancer Genet Cytogenet 159:137-42. 2005..These specific alterations were found almost exclusively in patients with a history of tobacco smoking. The results did not indicate that general chromosomal abnormalities are a useful marker for tobacco smoke exposure or cancer risk...